4-7-8 Breathing for Fatigue and Sleep Management in Hemodialysis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorIzmir Kavram Vocational School

About this trial

For many hemodialysis patients, fatigue and sleep disturbances are common and debilitating side effects that severely impact daily life and quality of life. In this study, patients will be taught a simple breathing exercise called the 4-7-8 technique to help manage these symptoms. A total of 80 adult patients undergoing regular hemodialysis at Izmir Atatürk Training and Research Hospital will be randomly assigned to two groups: an intervention group and a control group. Participants in the intervention group will receive a face-to-face training session from a research nurse and a short instructional video sent to their smartphones to encourage daily home practice, especially before bedtime. The program will be continued over the study period. Participants in the control group will continue with their current routine hemodialysis care without any structured breathing exercises. Fatigue levels, sleep quality, and daytime sleepiness will be measured in both groups before and after the program using validated questionnaires. The results of this study may provide nurses and patients with a safe, cost-effective, non-drug option to improve symptom management and overall well-being in hemodialysis patients.

Eligibility criteria

Qualifiers

Age between 18 and 85 years

Receiving hemodialysis treatment for at least 3 months

No diagnosis of malignant respiratory disease (e.g., bronchial or lung cancer)

No pathological condition affecting consciousness or focus (e.g., dialysis dementia or uremic encephalopathy)

Disqualifiers

Advanced reading comprehension problems

Advanced hearing impairment

Presence of sleep apnea

Known psychiatric illness.

Trial design

Treatments tested in this trial

  • Breathing technique

Treatment groups

80 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators